Print

Supernus Pharmaceuticals (SUPN) Reports Second Quarter 2012 Financial Results  
8/10/2012 9:32:03 AM

ROCKVILLE, Md., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today reported consolidated financial results for the three and six months ending June 30, 2012, and provided an update on key accomplishments to date and expected milestones for 2012.
//-->